Using OMOP CDM for clinical trials, simulation, or adaptive trials?
Review, Evaluate, and Validate the frailty score
[Patient Level Prediction Workgroup] Meetings
Negative information in OMOP CDM
Opportunity to help the hepatocellular carcinoma research community
ACEI ARB and Lung Ca
Difference between Condition Era and Condition Group Era
Phenotyping Endometriosis Network Study Feasibility
Risk Factors of Cerebral Hemorrhagic Infarction in Patients Using Anticoagulant Drugs for Cerebral Ischemic Infarction
File based OMOP implementation in multinational PASS study
Interest in sharing pretrained deep learning models from OMOP CDM?
Commit History of StudyProtocolSandbox repository was lost for 5 days
Outcomes count in Cohort Method Data
Enasidenib and Cholangiocarcinoma
How to fit outcome model with only specified covariates using CohortMethod package?
Drug exposure on specific visit
OHDSI Informatics Study: Data Quality
Comparing covariates between outcome and target cohort using FeatureExtraction
Cohort Features vs Сharacterization Reports in Atlas
Cancer statistics across OHDSI networks: ONCO-ACHILLES
First Exposure attribute vs earliest event
Atlas- OHDSI version tooooo slow -- Local Version
Where do I find the person_ids that are the result of the CohortMethod?
Interesting study about the impact of analytic choices on the obtained results
**Searching for collaborators to validate APHRODITE phenotyping models**
Is the future of phenotyping here today? Papers you've got to read from the OHDSI community
Original vs. generic medicine: For valsartan
'Data Enclaves for Sharing Information Derived From Clinical and Administrative Data' From JAMA
OhdsiStudy2 - How to generate the treatment pathway figures
Treatment Pathways Study - SQL Query
← previous page
next page →